Showing 1 - 10 of 2,010
In this paper we set up an overlapping generations model of gerontological founded human aging that takes the interaction between R&D-driven medical progress and access to health care into account. We use the model to explore potential futures of human health and longevity. For the baseline...
Persistent link: https://www.econbiz.de/10011794846
In this paper we set up an overlapping generations model of gerontological founded human aging that takes the interaction between R&D-driven medical progress and access to health care into account. We use the model to explore potential futures of human health and longevity. For the baseline...
Persistent link: https://www.econbiz.de/10011739423
Persistent link: https://www.econbiz.de/10012597755
Persistent link: https://www.econbiz.de/10011819248
Persistent link: https://www.econbiz.de/10003712112
Persistent link: https://www.econbiz.de/10003511226
Persistent link: https://www.econbiz.de/10003986619
Aging humans adapt to their worsening state of health and old people are usually happier than estimated by young individuals. In this paper we investigate how adaptation to a deteriorating state of health affects health spending, life expectancy, and the value of life. We set up a a life cycle...
Persistent link: https://www.econbiz.de/10011388100
Persistent link: https://www.econbiz.de/10010496312
This paper discusses the relationship between medical innovations and ageing from a health economics perspective and surveys empirical evidence on medical R&D incentives, R&D costs of pharmaceuticals, and the cost-effectiveness of health innovations. Particular focus is on the endogeneity of...
Persistent link: https://www.econbiz.de/10012653346